Merck Beats Views on Sales Jumps for Cancer Drugs, Vaccines

By THE ASSOCIATED PRESS
NYT
Soaring sales of cancer drugs, vaccines and veterinary medicines drove Merck & Co.'s 5 percent jump in second-quarter revenue and the company lifted its outlook for the year.
Published date: July 27, 2018 at 02:09PM
AP
New York Times article